North Dakota State Investment Board Makes New Investment in GE HealthCare Technologies Inc. $GEHC

North Dakota State Investment Board bought a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the fourth quarter, Holdings Channel.com reports. The fund bought 15,698 shares of the company’s stock, valued at approximately $1,288,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Western Wealth Management LLC lifted its position in GE HealthCare Technologies by 2.4% in the fourth quarter. Western Wealth Management LLC now owns 5,240 shares of the company’s stock worth $430,000 after purchasing an additional 125 shares during the period. United Community Bank lifted its position in GE HealthCare Technologies by 10.2% in the fourth quarter. United Community Bank now owns 1,410 shares of the company’s stock worth $116,000 after purchasing an additional 130 shares during the period. Thoma Capital Management LLC lifted its position in GE HealthCare Technologies by 1.4% in the fourth quarter. Thoma Capital Management LLC now owns 9,918 shares of the company’s stock worth $814,000 after purchasing an additional 136 shares during the period. Colonial Trust Advisors lifted its position in GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after purchasing an additional 139 shares during the period. Finally, Norinchukin Bank The lifted its position in GE HealthCare Technologies by 0.4% in the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after purchasing an additional 149 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies News Roundup

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Argus kept a Buy rating on GE HealthCare while lowering its price target to $80 from $95, suggesting analysts still see upside from current levels despite trimming expectations. Article Link
• Neutral Sentiment: Another report said GE HealthCare is receiving an average analyst rating of Hold, which points to cautious sentiment but does not by itself change the investment case. Article Link
• Negative Sentiment: Kirby McInerney LLP said it is investigating potential claims involving GE HealthCare and possible violations of federal securities laws, adding to legal uncertainty for shareholders. Article Link
• Negative Sentiment: Bragar Eagel & Squire also said it continues investigating GEHC on behalf of stockholders, reinforcing the litigation overhang. Article Link
• Negative Sentiment: Glancy Prongay Wolke & Rotter announced a securities-fraud investigation into GE HealthCare, and Law Offices of Howard G. Smith separately launched a similar probe, increasing concerns about potential legal costs and reputational damage. Article Link Article Link

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $61.56 on Wednesday. The stock has a market capitalization of $28.00 billion, a P/E ratio of 14.73, a P/E/G ratio of 1.38 and a beta of 0.74. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The business’s fifty day moving average is $69.02 and its two-hundred day moving average is $76.48. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.95 and a current ratio of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the prior year, the company posted $1.01 EPS. GE HealthCare Technologies’s quarterly revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current fiscal year.

Insider Activity at GE HealthCare Technologies

In other news, insider Frank R. Jimenez bought 1,750 shares of the business’s stock in a transaction on Thursday, April 30th. The shares were bought at an average cost of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider directly owned 93,932 shares in the company, valued at $5,678,189.40. This trade represents a 1.90% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO James Saccaro bought 3,310 shares of the business’s stock in a transaction on Friday, May 1st. The shares were purchased at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the completion of the purchase, the chief financial officer owned 87,471 shares in the company, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders acquired 11,847 shares of company stock worth $719,555. Insiders own 0.36% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on GEHC. Piper Sandler cut their target price on GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Wells Fargo & Company dropped their price target on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a report on Thursday, April 30th. Stifel Nicolaus set a $80.00 price target on GE HealthCare Technologies in a report on Wednesday, April 29th. Barclays dropped their price target on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Finally, Evercore set a $80.00 price target on GE HealthCare Technologies in a report on Thursday, April 30th. Nine analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Hold” and an average target price of $80.63.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.